ANIX icon

Anixa Biosciences
ANIX

Overview Fund Activity

29 hedge funds and large institutions have $11.8M invested in Anixa Biosciences in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+7
Holders Change %
+31.82%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.99M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$790K
3
RJA
3
Raymond James & Associates
Florida
$198K
4
Jane Street
4
Jane Street
New York
$122K
5
WAAG
5
Wealth Alliance Advisory Group
Kansas
$94K

Top Sellers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$62K
2
UBS Group
2
UBS Group
Switzerland
$2.75M
3
Morgan Stanley
3
Morgan Stanley
New York
$41K
4
HPCM
4
Hunter Perkins Capital Management
Illinois
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
26
Accel Wealth Management
Iowa
$6K +$6K +1,250 New
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$3K -$1.37K -296 -31%
HPCM
28
Hunter Perkins Capital Management
Illinois
– -$54K -17,653 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$44K -14,218 Closed
ASN
30
Advisory Services Network
Georgia
– -$1K -400 Closed
1
2